Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000412462 | SCV000486498 | likely pathogenic | Niemann-Pick disease, type C1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000412462 | SCV003443333 | pathogenic | Niemann-Pick disease, type C1 | 2023-11-07 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 1189 of the NPC1 protein (p.Glu1189Gly). This variant is present in population databases (rs369098773, gnomAD 0.004%). This missense change has been observed in individual(s) with Niemann-Pick Type C (PMID: 11349231, 12205649, 26666848). ClinVar contains an entry for this variant (Variation ID: 371037). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NPC1 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Genomics England Pilot Project, |
RCV000412462 | SCV001760423 | pathogenic | Niemann-Pick disease, type C1 | no assertion criteria provided | clinical testing |